Opioids Related Content

Dr. Weiss’ career has focused on treatment and clinical research with substance-dependent patients. He has received numerous NIH grants, including for developing integrated group therapy, an evidence-based treatment for co-occurring bipolar and substance use disorders, and leading a multi-site...

Shelly F. Greenfield, MD, MPH, is an addiction psychiatrist, clinician, and researcher. She serves as principal and co-investigator on federally funded research focusing on substance use disorders treatment, gender differences, and substance health services. She received a National Institute on Drug...

Hilary S. Connery, MD, PhD, is an assistant professor of psychiatry at Harvard Medical School and serves as the clinical director for McLean Hospital’s Division of Alcohol, Drugs, and Addiction. Dr. Connery’s expertise includes treatment of opioid use disorders and integrated treatments for co...

Jennifer Keller, BSN, RN, joined the team at Fernside, a McLean Signature Addiction Recovery Program, in 2014. She worked first as a staff nurse before transitioning to her current role as nurse manager. In her position, Ms. Keller facilitates groups focused on topics such as preventing addiction...

Laura Erwin, PhD, is a post-doctoral research fellow in the Preclinical Pharmacology Program at McLean Hospital. Her research focuses on elucidating the pharmacological mechanisms and neurobiology that mediate the behavioral effects of drug of abuse. Dr. Erwin received her PhD at LSU Health Sciences...

Quinn Tremblay has previously worked as a middle school teacher, a high school coach, and management in community-based housing in partnership with the Massachusetts Department of Mental Health. When Fernside opened in 2006, she joined the team, originally in a direct care position before becoming...

Bertha K. Madras, PhD, is a professor of psychobiology at Harvard Medical School, based at McLean Hospital and cross appointed at the Massachusetts General Hospital. Her research focuses on neurobiology, imaging, and medications development (19 U.S. and 27 international patents) for neuropsychiatric...

Rocco A. Iannucci, MD, began his psychiatric career at Massachusetts General Hospital and McLean Hospital, where he served as chief resident in addiction psychiatry and as assistant director of psychiatric residency training. In 2008, he entered a practice at the Berkshire Medical Center, serving as...

Elena H. Chartoff, PhD, is an associate professor of psychiatry at Harvard Medical School and director of the Neurobiology of Motivated Behavior Laboratory at McLean Hospital. She is interested in the neurobiological mechanisms that connect depression and anxiety with drug addiction. The work in her...

Karsten Kueppenbender, MD, is an addiction psychiatrist who provides individual psychotherapy, case formulations, and substance use disorder consultations at The Pavilion. He also provides comprehensive psychiatric evaluations and treatment at the LEADER residence for men, a treatment program for...

Gerardo Gonzalez-Haddad, MD, is the medical director of McLean’s Addiction Treatment Center at Naukeag and an associate professor of psychiatry at Harvard Medical School. He has more than 20 years of experience in clinical services, research, and teaching in addiction psychiatry. Dr. Gonzalez-Haddad...

Allen J. Bailey, PhD, is a clinical investigator in the Division of Alcohol, Drugs, and Addiction at McLean Hospital. His research aims to understand heterogeneity among individuals with substance use disorders (SUD) and to improve treatment outcomes in SUD populations. He is particularly interested...